AGM Statement

Inspiration Healthcare Group plc

("Inspiration Healthcare", or the "Company") 

AGM Statement

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company will hold its Annual General Meeting at 11.30am today and the Chairman, Mr Mark Abrahams, will give the following statement to shareholders:

"When we published our financial results in April 2019, I stated that we had started the new financial year with a very healthy order book. I'm delighted to report that initial trading has been consistent with this position and remains in line with management's expectations.

The significant investment made over the last two years to develop new products, strengthen our operational team and obtain accreditation for our new products has put us in a strong position to increase sales of the higher margin products such as our Patient Warming System and to increase revenues. In the coming year, we expect to continue to increase the level of international sales, as we work with our distributors to develop markets and to search for opportunities that will ensure the Company becomes a world leader in Neonatal Intensive Care.

We are actively engaged with a wide range of experts and thought leaders in hospitals and Universities all over the world who are developing new technology to improve outcomes for patients. When an opportunity presents itself we will actively invest in these projects in order to fully develop them as commercial opportunities. Recently we announced signing a licence agreement with a major US based University ("Project Wave") and we look forward to being able to update shareholders on this exciting project as the year progresses"

Enquiries:

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com